Literature DB >> 1734312

Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis.

P L Silbert1, W V Knezevic, D T Bridge.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1734312     DOI： 10.1212/wnl.42.1.257

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  Adverse effects of intravenous immunoglobulin therapy.

Authors:  U E Nydegger; M Sturzenegger
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

2.  Encephalopathy associated with intravenous immunoglobulin treatment for Guillain-Barré syndrome.

Authors:  K Harkness; S J Howell; G A Davies-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

Review 3.  Intravenous immunoglobulin in neurological disease: a specialist review.

Authors:  C M Wiles; P Brown; H Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; J H Rees; M R Rose; N Scolding; A D B Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

4.  Progressive multifocal leukoencephalopathy in patients with AIDS: detection of JC virus DNA in CSF and brain.

Authors:  C J Perrons; R J Chinn; J D Fox; S B Lucas; M J Harrison; R F Miller
Journal:  Genitourin Med       Date:  1995-02

Review 5.  Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.

Authors:  Matthias Wittstock; Uwe K Zettl
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

6.  AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis.

Authors:  Per M Humpert; Ivan K Lukic; Suzanne R Thorpe; Stefan Hofer; Ezzat M Awad; Martin Andrassy; Elizabeth K Deemer; Michael Kasper; Erwin Schleicher; Markus Schwaninger; Markus A Weigand; Peter P Nawroth; Angelika Bierhaus
Journal:  J Leukoc Biol       Date:  2009-04-28       Impact factor: 4.962

Review 7.  Adverse effects of intravenous immunoglobulin.

Authors:  S A Misbah; H M Chapel
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

8.  Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial.

Authors:  Nobuyuki Miyasaka; Masako Hara; Takao Koike; Eizo Saito; Masahito Yamada; Yoshiya Tanaka
Journal:  Mod Rheumatol       Date:  2011-10-05       Impact factor: 3.023
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.